Originally founded by an anonymous developer named Satoshi Nakamoto in 2009, Bitcoin (BTC) is the most widely used and popular cryptocurrency in circulation today. New Bitcoins are still being created ...

Michael Saylor is the executive chairman and co-founder of MicroStrategy, a company that issues equity and debt to buy ...

Meanwhile, the crypto market has also undergone major fluctuations, particularly with the ETH/BTC price ratio, which tracks ...

Bitcoin (BTC-USD) on Saturday was hovering just under the historic $100K milestone, taking a bit of a breather after another ...

Altcoin season looms as TOTAL3 hits $936B and Layer 1 tokens rally. Pro-crypto sentiment and rising spot volumes drive market momentum.

Bitcoin prediction markets still see $100,000 hitting by New Year despite mounting BTC price selling pressure.

Discover how the YieldMax MSTR Option Income Strategy ETF (MSTY) maximizes gains through call-option-selling strategy in high ...

Shubham Pant, MD, MBBS, discussed the use of zanidatamab and the HERIZON-BTC-01 trial in HER2-positive biliary tract cancer ...

Analyzing the risks and benefits of investing in MSTY and MSTR in a volatile market influenced by BTC/USD movements.

If the Senate confirms Bessent, the next person whose signature is on the front of paper U.S. currency will be a fan of ...

Citron said it had hedged its perspective with a short position against MicroStrategy, even though it maintained a positive ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...